Growing number of U.S. adults wrongly think vaping is more harmful than smoking cigarettes, study shows

Health groups urge Bhattacharya, in his position of acting CDC director, to restore staff in the Office on Smoking and Health

A coalition of public health groups sent a formal letter to NIH Director and Acting CDC Director Jay Bhattacharya April 15 highlighting the need for the immediate restoration of full staffing and resources to the CDC’s Office on Smoking and Health.

Sen. Susan Collins and patient advocate Jill Feldman are recognized with AACR Distinguished Service Awards

The American Association for Cancer Research will honor leaders from government and the advocacy community with awards for distinguished service in support of cancer research at the AACR Annual Meeting 2026 to be held April 17-22 in San Diego.

April 17, 2026

Vol.52 No.15

Clinical Roundup

E-cigarette taxes reduce vaping; no increase in adult smoking, OSU study finds

For years, a central debate in tobacco policy has been whether taxing e-cigarettes might unintentionally drive vapers back to traditional cigarettes.

April 17, 2026

Vol.52 No.15

Clinical Roundup

Lung cancer surgery safe for many patients over 80, Mount Sinai study finds

Adults aged 80 and older with early-stage lung cancer can safely undergo surgery and achieve outcomes comparable to younger patients, challenging longstanding assumptions about age and cancer treatment, according to a study led by researchers at the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center.

April 10, 2026

Vol.52 No.14

Clinical Roundup

Researchers at VCU identify Achilles’ heel in lung cancer through common genetic mutation

A team of researchers at VCU Massey Comprehensive Cancer Center has identified a new pathway through which mutations in the tumor suppressor p53 gene—found very frequently in human tumors—hijack DNA replication in cancer cells.

March 13, 2026

Vol.52 No.10

Clinical Roundup

Lung cancer drug offers a surprising new treatment against ovarian cancer, Mayo study finds

Ovarian cancer cells may quickly activate a survival response after PARP inhibitor treatment, and blocking this early response may make this class of drugs work better, a study published by Mayo Clinic researchers suggests.

February 20, 2026

Vol.52 No.07

Growing number of U.S. adults wrongly think vaping is more harmful than smoking cigarettes, study shows

YOU MAY BE INTERESTED IN

Health groups urge Bhattacharya, in his position of acting CDC director, to restore staff in the Office on Smoking and Health

Sen. Susan Collins and patient advocate Jill Feldman are recognized with AACR Distinguished Service Awards

E-cigarette taxes reduce vaping; no increase in adult smoking, OSU study finds

Lung cancer surgery safe for many patients over 80, Mount Sinai study finds

Researchers at VCU identify Achilles’ heel in lung cancer through common genetic mutation

Lung cancer drug offers a surprising new treatment against ovarian cancer, Mayo study finds

Renew today!

Subscriber content

Never miss an issue!

Login